Treatment Of Breast Cancer; Review And Updates

Muhammad Furrukh, Asim Qureshi

Research output: Contribution to journalReview article

Abstract

Cancer of the breast is the leading female cancer accounting for one fourth of the malignancies. The tumour remains the most researched, read and practiced upon around the Globe. The treatment has substantially improved breast cancer related outcomes, both for early as well as late stages with substantial improvements in disease free and overall survival. Therapeutic decisions not only rest on clinical & tumour characteristics, but also with the evolution of molecular biology and tissue microarray intrinsic sub-types have been found. Attempts are being made to translate therapy from genomic architecture of individual breast cancer. This facilitates customization of treatment avoiding un-necessary toxicity, costs and inconvenience. Optimizing treatment based on individual breast biology seems logical and allows unifying treatment. The paper reviews literature, incorporate updates and also describes immunohistochemistry based molecular classification: which are found simple to adapt, record, present and subsequently manage, summarizing clinical practices in management of these patients.

Original languageEnglish
Pages (from-to)264-274
Number of pages11
JournalJournal of Ayub Medical College, Abbottabad : JAMC
Volume30
Issue number2
Publication statusPublished - Apr 1 2018

Fingerprint

Breast Neoplasms
Neoplasms
Therapeutics
Practice Management
Disease-Free Survival
Molecular Biology
Breast
Immunohistochemistry
Costs and Cost Analysis

Keywords

  • Antibodies, Monoclonal
  • Breast
  • Cancer; Molecular biology
  • Immunohistochemistry
  • Receptor, erb-B2;Therapy
  • Triple negative

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Treatment Of Breast Cancer; Review And Updates. / Furrukh, Muhammad; Qureshi, Asim.

In: Journal of Ayub Medical College, Abbottabad : JAMC, Vol. 30, No. 2, 01.04.2018, p. 264-274.

Research output: Contribution to journalReview article

@article{796873d23a1e4172b5d96e0c2cf1aabf,
title = "Treatment Of Breast Cancer; Review And Updates",
abstract = "Cancer of the breast is the leading female cancer accounting for one fourth of the malignancies. The tumour remains the most researched, read and practiced upon around the Globe. The treatment has substantially improved breast cancer related outcomes, both for early as well as late stages with substantial improvements in disease free and overall survival. Therapeutic decisions not only rest on clinical & tumour characteristics, but also with the evolution of molecular biology and tissue microarray intrinsic sub-types have been found. Attempts are being made to translate therapy from genomic architecture of individual breast cancer. This facilitates customization of treatment avoiding un-necessary toxicity, costs and inconvenience. Optimizing treatment based on individual breast biology seems logical and allows unifying treatment. The paper reviews literature, incorporate updates and also describes immunohistochemistry based molecular classification: which are found simple to adapt, record, present and subsequently manage, summarizing clinical practices in management of these patients.",
keywords = "Antibodies, Monoclonal, Breast, Cancer; Molecular biology, Immunohistochemistry, Receptor, erb-B2;Therapy, Triple negative",
author = "Muhammad Furrukh and Asim Qureshi",
year = "2018",
month = "4",
day = "1",
language = "English",
volume = "30",
pages = "264--274",
journal = "Journal of Ayub Medical College, Abbottabad : JAMC",
issn = "1025-9589",
publisher = "Ayub Medical College",
number = "2",

}

TY - JOUR

T1 - Treatment Of Breast Cancer; Review And Updates

AU - Furrukh, Muhammad

AU - Qureshi, Asim

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Cancer of the breast is the leading female cancer accounting for one fourth of the malignancies. The tumour remains the most researched, read and practiced upon around the Globe. The treatment has substantially improved breast cancer related outcomes, both for early as well as late stages with substantial improvements in disease free and overall survival. Therapeutic decisions not only rest on clinical & tumour characteristics, but also with the evolution of molecular biology and tissue microarray intrinsic sub-types have been found. Attempts are being made to translate therapy from genomic architecture of individual breast cancer. This facilitates customization of treatment avoiding un-necessary toxicity, costs and inconvenience. Optimizing treatment based on individual breast biology seems logical and allows unifying treatment. The paper reviews literature, incorporate updates and also describes immunohistochemistry based molecular classification: which are found simple to adapt, record, present and subsequently manage, summarizing clinical practices in management of these patients.

AB - Cancer of the breast is the leading female cancer accounting for one fourth of the malignancies. The tumour remains the most researched, read and practiced upon around the Globe. The treatment has substantially improved breast cancer related outcomes, both for early as well as late stages with substantial improvements in disease free and overall survival. Therapeutic decisions not only rest on clinical & tumour characteristics, but also with the evolution of molecular biology and tissue microarray intrinsic sub-types have been found. Attempts are being made to translate therapy from genomic architecture of individual breast cancer. This facilitates customization of treatment avoiding un-necessary toxicity, costs and inconvenience. Optimizing treatment based on individual breast biology seems logical and allows unifying treatment. The paper reviews literature, incorporate updates and also describes immunohistochemistry based molecular classification: which are found simple to adapt, record, present and subsequently manage, summarizing clinical practices in management of these patients.

KW - Antibodies, Monoclonal

KW - Breast

KW - Cancer; Molecular biology

KW - Immunohistochemistry

KW - Receptor, erb-B2;Therapy

KW - Triple negative

UR - http://www.scopus.com/inward/record.url?scp=85054897722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054897722&partnerID=8YFLogxK

M3 - Review article

VL - 30

SP - 264

EP - 274

JO - Journal of Ayub Medical College, Abbottabad : JAMC

JF - Journal of Ayub Medical College, Abbottabad : JAMC

SN - 1025-9589

IS - 2

ER -